Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 8, 2025

Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis.

View Full Paper
Ask AI
Bookmark
Share

Authors

TITakanobu IshiguroKKKensaku Kasuga

Discussion

Loading...

Member takes

Overview

This review unpacks current and emerging biomarkers in Alzheimer's disease, highlighting diagnostic criteria and clinical implications.

Key Points

  • Recent technological advancements have enhanced the diagnosis of alzheimer's disease, improving treatment strategies.
  • Cerebrospinal fluid biomarkers and imaging methods are now standard tools for identifying early-stage alzheimer's disease.
  • Revised diagnostic criteria integrating biomarker-based assessments and clinical stages are set to formalize in 2024.
  • Emerging blood-based biomarkers offer promising, less invasive options for the early detection of alzheimer's disease.

Cite This Study

Ishiguro et al. (2025) studied this question.

synapsesocial.com/papers/68e6d7971ffa7aa7d63d164ahttps://doi.org/10.11477/mf.030126030530050923
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions2025 · 5 citations
  2. 2From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer’s Disease2025 · 11 citations
  3. 3The Role of Blood-Based Biomarkers in Transforming Alzheimer’s Disease Research and Clinical Management: A Review2025 · 18 citations
  4. 4Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and Prognostics2024 · 13 citations
  5. 5From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape2025 · 5 citations